Dominici MNichols KSrivastava AWeiss D.JEldridge PCuende NDeans R.JRasko J.E.JLevine A.DTurner LGriffin D.LO'Donnell LForte MMason CWagena EJanssen WNordon RWall DHONG-NERNG HORuiz M.AWilton SHorwitz E.MGunter K.C.2020-02-172020-02-1720151465-3249https://scholars.lib.ntu.edu.tw/handle/123456789/460004[SDGs]SDG3cell therapy; clinical effectiveness; clinical practice; economic development; Editorial; health care cost; health care policy; health personnel attitude; human; medical research; medical society; patient decision making; patient safety; priority journal; publication; risk assessment; risk factor; social status; biological therapy; evidence based medicine; medical society; standards; Cell- and Tissue-Based Therapy; Evidence-Based Medicine; Humans; Patient Safety; Societies, Medicaleditorial10.1016/j.jcyt.2015.10.007265897502-s2.0-84947583373